Financial Snapshot

Revenue
$29.11M
TTM
Gross Margin
55.65%
TTM
Net Earnings
-$827.0K
TTM
Current Assets
Q3 2023
Current Liabilities
Q3 2023
Current Ratio
11.94%
Q3 2023
Total Assets
Q3 2023
Total Liabilities
Q3 2023
Book Value
-$36.78M
Q3 2023
Cash
Q3 2023
P/E
-27.08
Mar 20, 2024 EST
Free Cash Flow
-$2.904M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $22.394 Million

About Unrivaled Brands, Inc.

Unrivaled Brands, Inc. is a holding company, which engages in the retail, cultivation, and production of medical cannabis and agricultural products. The company is headquartered in Santa Ana, California and currently employs 145 full-time employees. The company went IPO on 2011-02-10. The firm is engaged in providing medical and adult use cannabis products. The firm offers Korova, a brand of high potency products across multiple product categories, available in California, Oregon, Arizona, and Oklahoma. The company operates through two segments, namely Cannabis Retail and Cannabis Cultivation and Distribution. Cannabis Retail includes cannabis-focused retail, both physical stores and non-store front delivery. Cannabis Cultivation and Distribution includes cannabis cultivation, production, and distribution operations Either independently or in conjunction with third parties, the Company operates medical marijuana retail and adult use dispensaries and cultivation and production facilities in California. The company operates four cannabis dispensaries in California: People's in Santa Ana, The Spot in Santa Ana, Blum in Oakland, and Blum in San Leandro.

Industry: Retail-Miscellaneous Retail Peers: Ampio Pharmaceuticals, Inc. cbdMD, Inc. PLx Pharma Winddown Corp. Evofem Biosciences, Inc. Jaguar Health, Inc. JOHNSON & JOHNSON VYNE Therapeutics Inc. Pulmatrix, Inc. WEED, INC. Virpax Pharmaceuticals, Inc.